Search results
South Africa’s Afrigen targets local diseases with mRNA vaccines
Semafor via Yahoo News· 2 days agoSouth African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist's team...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 3 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Molecular Identification of Fonsecaea monophora, Novel Agent of Fungal Brain Abscess
Centers for Disease Control and Prevention· 1 day agoA 3-year-old boy was admitted to the All India Institute of Medical Sciences, New Delhi, India, with headache for 3 weeks and 2 episodes of seizures. Fundoscopic examination revealed bilateral ...
Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
Insider Monkey via Yahoo Finance· 2 days agoIn this article, we will be taking a look at is Eli Lilly and Company the largest publicly traded...
Could the internet be ... good for you? Here's what to know about this week's health headlines
Yahoo Life Style via AOL· 6 days ago...this increase will be due to public health measures that reduce deaths from various communicable...
Asthma, COPD often not diagnosed, study indicates
UPI· 5 days agoFinding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for...
Bayer: The pharmaceutical company behind Leverkusen's success - and its difficult past
New York Times· 4 days agoUnder head coach Xabi Alonso, Bayer Leverkusen have won the Bundesliga and are on the cusp of...
Evotec (EVO) to Release Earnings on Wednesday
ETF DAILY NEWS· 4 days agoEvotec (NASDAQ:EVO – Get Free Report) is set to release its earnings data before the market opens on Wednesday, May 22nd. Analysts expect Evotec to post earnings of ($0.07) per share for the ...
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 4 days agoIn Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active Crohn's disease, with or without previous biologic failure, achieved statistically ...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced the availability of SIMLANDI (adalimumab-ryvk ...